The funds will support the development of Ascentage’s pipeline, including its lead candidate olverembatinib to treat blood ...

Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s ...

Phoenix Asia Holdings faces significant risks, including regulatory risks, customer concentration and uncertainties in the ...

EcoCeres Inc., a producer of sustainable fuel backed by Bain Capital, is exploring an initial public offering that could ...

The China-based drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is ...

A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.

Smithfield Foods on Tuesday unveiled terms for its planned initial public offering, with the largest U.S. pork producer ...

(Reuters) - Smithfield Foods is targeting a valuation of up to $10.73 billion in its U.S. initial public offering, the ...

Chinese biotech Ascentage Pharma has taken the first US biotech initial public offering (IPO) of 2025 over the finish line, ...

Hong Kong Pharma Digital Technology (HKPD) stock was down 21% Wednesday afternoon following a $4M U.S. initial public ...

Chinese soda maker Dayao is gearing up for a Hong Kong initial public offering (IPO) as early as the second half of the year, ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...